Press Releases about Optimi Health Corp
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
October 05, 2022
Via PressReach
Topics
Cannabis
Exposures
Cannabis
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
October 05, 2022
Topics
Cannabis
Exposures
Cannabis
Optimi Health and ATMA Journey Centers to Send a Clinical Trial Application to Health Canada for Phase I Natural Psilocybin and MDMA
September 22, 2022
Via PressReach
Topics
Supply Chain
Exposures
Supply Chain
Psychedelics May Make People Less Afraid of Death
September 07, 2022
Topics
Supply Chain
Exposures
Supply Chain
Psychedelics Use Among Young Adults Reaches All-Time High
September 01, 2022
Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression
August 10, 2022
Topics
Supply Chain
Exposures
Supply Chain
Optimi Health Natural Psilocybin Extraction Breakthrough Submitted for Provisional Patent Application
October 05, 2021
Topics
Intellectual Property
Exposures
Intellectual Property
Optimi Health Initiates Pathway to Nasdaq Listing
July 07, 2021
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.